India's Risk-Based Pharma Inspection Plan: Well Begun?
This article was originally published in SRA
Executive Summary
India's Central Drugs Standard Control Organization (CDSCO) is taking definitive steps to strengthen its drug regulatory regime and enforcement, including across areas such as data integrity, in the backdrop of industry's patchy manufacturing compliance history.